Cargando…
Thrombotic and Hypercoagulability Complications of COVID-19: An Update
The current COVID-19 pandemic emerged in December 2019, in China, affecting millions of people worldwide. COVID-19 is mainly a disease of the respiratory system, yet systematic complications have also been reported among SARS-CoV-2 infected patients. Thrombotic complications are one of the severe cl...
Autores principales: | Shibeeb, Sapha, Ahmad, Muneera Naseer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421041/ https://www.ncbi.nlm.nih.gov/pubmed/34512059 http://dx.doi.org/10.2147/JBM.S316014 |
Ejemplares similares
-
ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a review
por: Shibeeb, Sapha, et al.
Publicado: (2022) -
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
por: Haimei, MA
Publicado: (2020) -
Management of Thrombotic Complications in COVID-19: An Update
por: Hajra, Adrija, et al.
Publicado: (2020) -
Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review
por: Shibeeb, Sapha, et al.
Publicado: (2022) -
Hypercoagulability of COVID-19 and Neurological Complications: A Review
por: Moore, Patrick, et al.
Publicado: (2022)